ClinicalTrials.Veeva

Menu

A Cohort of Patients Undergoing Percutaneous Coronary Intervention (APCIcohort)

S

Su Guohai

Status

Enrolling

Conditions

Unstable Angina
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Myocardial Infarction

Study type

Observational

Funder types

Other

Identifiers

NCT05719545
2021-206-02

Details and patient eligibility

About

To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and followed up for at least 2 years.

Full description

Patients with acute coronary syndrome undergoing percutaneous coronary intervention will be recruited and prospectively followed up for the incidence of major adverse cardiovascular events (MACE events), including all-cause mortality, cardiovascular mortality, ischemic stroke. Blood and fecal samples will be collected for further analysis. The basic and clinical information will be collected such as diagnosis, medical history, laboratory test results, therapy methods, prognosis and follow-up information. The risk factors involved in the occurrence and prognosis of acute coronary syndrome will be investigated.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
  • >18 years old.

Exclusion criteria

  • With malignant tumors, acute infectious diseases and advanced liver diseases.
  • Won't sign an inform consent.

Trial contacts and locations

1

Loading...

Central trial contact

Guohai Su, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems